Sponsor or institution

Clinical trials and research at Federation Francophone de Cancerologie Digestive

• 7Clinical trials
• 4Countries

Newest trials

All recruiting trials (7)

• Trifluridine/tipiracil plus fruquintinib versus trifluridine/tipiracil alone for metastatic oesogastric adenocarcinoma

  This will see if adding fruquintinib to trifluridine/tipiracil helps people with metastatic stomach or gastro‑oesophageal junction (G/GEJ) adenocarcinoma who have already received two or three prior treatments.

  Recruiting Phase 3 Federation Francophone de Cancerologie Digestive · Aurillac and 63 other locations · NCT07270991

• Prognostic Factors for Fruquintinib in Metastatic Colorectal Cancer

  This cohort study tests how clinical and biological factors relate to survival outcomes in adults with metastatic colorectal cancer treated with fruquintinib.

  Recruiting at 83 sites Federation Francophone de Cancerologie Digestive · Poitiers, France and 82 other locations · NCT07124858

• Observational study of rare primary liver cancers in France

  This study looks at rare types of liver cancer in France to see how they behave and how well different treatments work for patients.

  Recruiting at 29 sites Federation Francophone de Cancerologie Digestive · Amiens and 39 other locations · NCT06541652

• Evaluating biomarkers for immunotherapy resistance in metastatic colorectal cancer

  This study is trying to find out which patients with advanced colorectal cancer might not respond to a specific immunotherapy treatment called pembrolizumab, to help doctors choose the best options for their care.

  Recruiting at 3 sites Federation Francophone de Cancerologie Digestive · Bayonne and 19 other locations · NCT06353854

• New treatment approach for locally advanced anal cancer

  This study is testing a new treatment plan that combines chemotherapy and radiation to see if it can help people with advanced anal cancer live longer and have fewer relapses.

  Recruiting at 49 sites Phase 3 Federation Francophone de Cancerologie Digestive · Agen and 113 other locations · NCT06207981

• Combination treatment for localized colon or upper rectum cancer with BRAF mutation

  This study is testing a combination treatment of encorafenib and cetuximab for patients with localized colon or upper rectal cancer that has a specific BRAF mutation to see if it helps before surgery.

  Recruiting Phase 2 Federation Francophone de Cancerologie Digestive · Paris · NCT05706779

• Treatment for liver metastases in colorectal cancer

  This study is testing a new combination of chemotherapy treatments for patients with colorectal cancer that has spread to the liver, to see if it can help them live longer and feel better when surgery isn't an option.

  Recruiting at 35 sites Phase 3 Federation Francophone de Cancerologie Digestive · Brussels and 48 other locations · NCT02885753

Quick answers

How many clinical trials run by Federation Francophone de Cancerologie Digestive are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in France (7 trials), Germany (1 trial), Reunion (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →